‌

US Patent 11926646 C7 substituted oxysterols and methods of use thereof

Patent 11926646 was granted and assigned to SAGE Therapeutics on March, 2024 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

0

Patent attributes

Patent Applicant

SAGE Therapeutics

0

Current Assignee

SAGE Therapeutics

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Andrew Griffin0

Daniel La0

Boyd L. Harrison0

Albert Jean Robichaud0

Francesco G. Salituro0

Gabriel Martinez Botella0

Date of Patent

March 12, 2024

0

Patent Application Number

174761530

Date Filed

September 15, 2021

0

Patent Citations

US Patent 8673843 NMDA receptors modulators and uses thereof

0

US Patent 8829213 Liver X receptor agonists

0

US Patent 10201550 Oxysterols and methods of use thereof

0

US Patent 10227375 Neuroactive steroids and methods of use thereof

0

US Patent 10259840 Oxysterols and methods of use thereof

0

US Patent 10696712 Oxysterols and methods of use thereof

0

US Patent 10723758 Oxysterols and methods of use thereof

0

US Patent 10759828 Neuroactive steroids, compositions, and uses thereof

0

...

Patent Citations Received

US Patent 12129276 Oxysterols and methods of use thereof

0

Patent Primary Examiner

Kristin A Vajda

0

CPC Code

0

0

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11926646 C7 substituted oxysterols and methods of use thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.